CPHI vs DTE
China Pharma Holdings Inc (CPHI) versus DTE (DTE) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
DTE (DTE) common stock.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
DTE does not have a complete income-statement cache yet.
CPHI currently screens at market cap $29.0M. DTE currently screens at market cap $0.
Not investment advice. Open the CPHI and DTE stock pages for the full models.
Not investment advice.